Its major evidence-based and investigational research areas include: Reduction of visceral adipose tissue Endogenous GH, IGF-1, and IGFBP-3 activation Reduced waist circumference and trunk fat Modest increases in lean body mass Triglyceride and lipid-related changes Hepatic-fat research Exploratory skeletal-muscle composition findings Changes in body composition without substantial overall weight loss The strongest evidence applies to reducing excess abdominal fat in adults with HIV-associated lipodystrophy
Opt for the safer oral or topical options, and stay away from the risky intravenous injections
While weight loss drugs could still be viable option for you, either alone or in conjunction with weight loss surgery, its important to have a individualized tailored approach and consider long term outcomes
doi: 10.1056/NEJMoa1603827 253 MarsoSPBainSCConsoliAEliaschewitzFGJdarELeiterLAet al
Injectable: Compounded peptide protocols typically run $150$350 per month through a 503A pharmacy, depending on dose frequency and whether clinical consultation is bundled
conducted a 12-week study of the possible impacts of GHK-Cu peptide